Breaking News Instant updates and real-time market news.

PFE

Pfizer

$36.86

0.07 (0.19%)

08:19
01/08/18
01/08
08:19
01/08/18
08:19

Pfizer announces creation of new partnering model

Pfizer announced the creation of the Innovative Target Exploration Network, a new, early-stage partnering model that enables collaborative relationships with select academic institutions and principal investigators around the world, to identify research projects that have the potential to deliver novel therapeutic targets and mechanisms of action to underpin future drug discovery in core areas of interest to Pfizer. Complementing Pfizer's long-standing commitment to academic collaboration, the ITEN model will allow researchers from Pfizer and partner institutions to share ideas for pairing academia's cutting-edge research with industry's translational capabilities and wide network of resources and relationships. The University of Cambridge and the University of Oxford are the first to participate in the ITEN model in the United Kingdom, and the University of Texas Southwestern is the first to participate in the United States. Pfizer is seeking to selectively include other institutions to be part of the ITEN model.

  • 08

    Jan

  • 08

    Jan

  • 25

    Jan

  • 30

    Jan

  • 06

    Feb

  • 08

    Feb

  • 16

    Feb

PFE Pfizer
$36.86

0.07 (0.19%)

11/13/17
PIPR
11/13/17
NO CHANGE
Target $54
PIPR
Overweight
Pfizer still most compelling risk/reward in global pharma, says Piper Jaffray
Piper Jaffray analyst Richard Purkis says Pfizer remains the most compelling long-run risk/reward opportunity in his global pharma coverage universe. He believes the company's key growth assets, or Ibrance, Eliquis, Xtandi, Xeljanz and Bosulif, and pipeline are being underestimated by investors. Pfizer remains one of the analyst's top 2017 picks. Purkis reiterates an Overweight rating on the shares with a $54 price target.
11/13/17
BMOC
11/13/17
NO CHANGE
BMOC
BMO says Pfizer buying Biogen makes more sense than deal for Bristol-Myers
BMO Capital analyst Alex Arfaei noted the "significant market speculation" that Pfizer (PFE) is preparing to execute a large M&A deal. While many sources, including Bloomberg, have speculated that Pfizer could target Bristol-Myers (BMY), Arfaei argues that a deal for Biogen (BIIB) would make more sense. He believes Pfizer has a significant gap in neurology, particularly in Alzheimer's, where it cannot afford to remain on the sidelines as its peers - including Biogen, Merck (MRK), AstraZeneca (AZN), and Eli Lilly (LLY) - all have pivotal trials in that area reading out in 2019-2020. Pfizer could have an opportunity to leverage near-term volatility in Biogen's MS franchise to strike a deal during the next 6-9 months before a potential interim look on aducanumab, which Arfaei views as the strongest of the next wave of Alzheimer's drugs in development, he tells investors.
11/14/17
WELS
11/14/17
NO CHANGE
Target $12
WELS
Outperform
Pfizer ADHD drug supply shortage is positive for Neos, says Wells Fargo
Wells Fargo analyst David Maris says Pfizer (PFE) has sent a letter on physicians dated November 8th telling them of a supply shortage for its liquid and chewable methylphenidate ADHD products. Maris says Pfizer's product is a direct competitor of Neos' (NEOS) recently-launched Cotempla XR-ODT, adding Neos will benefit from having its primary competition in the alternative dose market facing a shortage. The analyst says Cotempla XR-ODT, launched in September, is off to a very strong start, keeping his Outperform rating with a $12 price target on Neos.
12/05/17
SBSH
12/05/17
NO CHANGE
Target $72
SBSH
Buy
Senate tax bill raises odds of Pfizer buying Bristol-Myers, says Citi
The Senate tax bill, which lowers the cost of bringing cash back home from outside the U.S., increases the probability of the "often-discussed" potential acquisition of Bristol-Myers Squibb (BMY) by Pfizer, Citi analyst Andrew Baum tells investors in a research note. The analyst points out that Pfizer has repeatedly underscored the importance of tax reform both from a competitive angle as well as from a merger perspective. Further, the analyst says that while Roche's (RHHBY) IMpower 150 Tecentriq lung cancer data in Geneva will take center stage this week, Bristol-Myers should benefit from two recent positive developments. The FDA's and Centers for Medicare and Medicaid Services' recommendation of Tumor Mutational Burden testing for lung cancer and other tumors will likely materially accelerate adoption and create more favorable reimbursement, Baum writes in a research note partially titled "Stars Converging for BMY." The analyst keeps a Buy rating on Bristol shares with a $72 price target. The stock closed yesterday down 76c to $62.47.

TODAY'S FREE FLY STORIES

ZSAN

Zosano Pharma

$0.47

0.0164 (3.64%)

10:55
01/23/18
01/23
10:55
01/23/18
10:55
Conference/Events
Zosano Pharma to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

OSTK

Overstock.com

$77.40

-0.25 (-0.32%)

10:50
01/23/18
01/23
10:50
01/23/18
10:50
Periodicals
Overstock ICO promotion 'false and misleading,' Medium contributor says »

A contributor to Medium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRP

Ctrip.com

$46.14

-0.71 (-1.52%)

10:50
01/23/18
01/23
10:50
01/23/18
10:50
Options
Short-term put buyers in Ctrip as shares stumble »

Short-term put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBLN

Obalon Therapeutics

$5.19

-0.05 (-0.95%)

10:46
01/23/18
01/23
10:46
01/23/18
10:46
Hot Stocks
Obalon Therapeutics terminates stock offering after whistleblower allegations »

Obalon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

TFX

Teleflex

$274.20

-0.55 (-0.20%)

10:44
01/23/18
01/23
10:44
01/23/18
10:44
Conference/Events
Leerink medical devices analysts hold an analyst/industry conference call »

Medical Devices Analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

  • 28

    Feb

  • 01

    Mar

TWTR

Twitter

$22.73

-0.5928 (-2.54%)

10:42
01/23/18
01/23
10:42
01/23/18
10:42
Recommendations
Twitter analyst commentary  »

Twitter data points to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

ILG

ILG

$29.45

-0.03 (-0.10%)

10:40
01/23/18
01/23
10:40
01/23/18
10:40
Options
Repeat interest in ILG Mar 30 calls »

Repeat interest in ILG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
01/23/18
01/23
10:35
01/23/18
10:35
Conference/Events
Morgan Stanley technology analyst holds an analyst/industry conference call »

Technology/Hardware…

ABEO

Abeona Therapeutics

$14.85

0.25 (1.71%)

, JKHY

Jack Henry

$125.32

0.17 (0.14%)

10:31
01/23/18
01/23
10:31
01/23/18
10:31
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

ABEO

Abeona Therapeutics

$14.85

0.25 (1.71%)

JKHY

Jack Henry

$125.32

0.17 (0.14%)

WWD

Woodward

$81.02

0.52 (0.65%)

NAV

Navistar

$44.96

0.21 (0.47%)

GBT

Global Blood Therapeutics

$56.35

2.4 (4.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

NFLX

Netflix

$227.58

7.12 (3.23%)

, GPRO

GoPro

$6.30

0.01 (0.16%)

10:31
01/23/18
01/23
10:31
01/23/18
10:31
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

NFLX

Netflix

$227.58

7.12 (3.23%)

GPRO

GoPro

$6.30

0.01 (0.16%)

W

Wayfair

$88.60

-2.04 (-2.25%)

FTNT

Fortinet

$45.85

-0.16 (-0.35%)

S

Sprint

$5.23

-0.091 (-1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 01

    Feb

  • 02

    Feb

  • 05

    Feb

  • 22

    Feb

DG

Dollar General

$103.69

1.424 (1.39%)

, DKS

Dick's Sporting

$34.91

0.29 (0.84%)

10:31
01/23/18
01/23
10:31
01/23/18
10:31
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

DG

Dollar General

$103.69

1.424 (1.39%)

DKS

Dick's Sporting

$34.91

0.29 (0.84%)

CAT

Caterpillar

$170.43

-0.46 (-0.27%)

RMD

ResMed

$101.77

14.26 (16.30%)

HPE

HP Enterprise

$16.37

0.315 (1.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 01

    Feb

SBUX

Starbucks

$61.41

0.15 (0.24%)

10:30
01/23/18
01/23
10:30
01/23/18
10:30
Options
Starbucks calls drawing interest ahead of earnings »

Starbucks calls drawing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

KMB

Kimberly-Clark

$117.35

0.4358 (0.37%)

10:29
01/23/18
01/23
10:29
01/23/18
10:29
Hot Stocks
Breaking Hot Stocks news story on Kimberly-Clark »

Kimberly-Clark:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

KMI

Kinder Morgan

$19.45

-0.18 (-0.92%)

10:28
01/23/18
01/23
10:28
01/23/18
10:28
Hot Stocks
Kinder Morgan begins operations of Utopia Pipeline system »

Kinder Morgan announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$117.26

0.35 (0.30%)

10:27
01/23/18
01/23
10:27
01/23/18
10:27
Hot Stocks
Breaking Hot Stocks news story on Kimberly-Clark »

Kimberly-Clark: China…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

PFIE

Profire Energy

$2.01

0.03 (1.52%)

10:26
01/23/18
01/23
10:26
01/23/18
10:26
Conference/Events
Profire Energy management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

NFLX

Netflix

$227.58

7.12 (3.23%)

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
Netflix management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

MLHR

Herman Miller

$40.95

0.4 (0.99%)

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
Herman Miller management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 30

    Jan

  • 31

    Jan

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
RBC Capital software analysts hold an analyst/industry conference call »

Software Analysts…

RARE

Ultragenyx

$53.39

4.23 (8.60%)

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
Ultragenyx participates in a conference call with JPMorgan »

Investor conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 17

    Apr

  • 24

    Jan

LLEX

Lilis Energy

$4.86

-0.14 (-2.80%)

10:24
01/23/18
01/23
10:24
01/23/18
10:24
Conference/Events
Lilis Energy management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 31

    Jan

EBAY

eBay

$39.58

1.15 (2.99%)

, GOOG

Alphabet

$1,155.81

18.3 (1.61%)

10:21
01/23/18
01/23
10:21
01/23/18
10:21
Periodicals
eBay CEO says shoppers are shifting to voice technology, CNBC reports »

eBay (EBAY) CEO Devin…

EBAY

eBay

$39.58

1.15 (2.99%)

GOOG

Alphabet

$1,155.81

18.3 (1.61%)

GOOGL

Alphabet Class A

$1,164.16

20.66 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

CMD

Cantel Medical

$112.00

0.7 (0.63%)

10:21
01/23/18
01/23
10:21
01/23/18
10:21
Conference/Events
Cantel Medical management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 31

    Jan

KMB

Kimberly-Clark

$116.87

-0.04 (-0.03%)

10:20
01/23/18
01/23
10:20
01/23/18
10:20
Hot Stocks
Kimberly-Clark sees 2H18 EPS higher than 1H18 »

On its Q4 earnings call,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

10:20
01/23/18
01/23
10:20
01/23/18
10:20
General news
Nasdaq leads major averages as Netflix jumps after earnings »

Stock futures were little…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.